<?xml version="1.0" encoding="UTF-8"?>
<records>
<record>
<language>eng</language>
<publisher>Science and Education Publishing</publisher>
<journalTitle>Journal of Food and Nutrition Research</journalTitle>
<eissn>2333-1240</eissn>
<publicationDate>2022-03-29</publicationDate>
<volume>10</volume>
<issue>4</issue>
<startPage>261</startPage>
<endPage>273</endPage>
<doi>10.12691/jfnr-10-4-2</doi>
<publisherRecordId>JFNR20221042</publisherRecordId>
<documentType>article</documentType>
<title language="eng">Ameliorative Effects of Lycopene on Diethylnitrosamine-Induced Hepatocarcinogenesis in Male Rats</title>
<authors>
<author>
<name>Ahmed Mohamed Mokhtar</name>
<affiliationId>1</affiliationId>
</author>
<author>
<name>Mohamed Fathy Elshafee</name>
<affiliationId>1</affiliationId>
</author>
<author>
<name>Ahmed Mohamed Mansour</name>
<affiliationId>1</affiliationId>
</author>
<author>
<name>El-Sayed Mohamed El-Sayed</name>
<email>elsayed200_1956@yahoo.com</email>
<affiliationId>1</affiliationId>
</author>

</authors>
<affiliationsList>
<affiliationName affiliationId="1">Pharmacology and Toxicology Department, Faculty of Pharmacy (Boys), Al-Azhar University, Nasr-City, Cairo, Egypt</affiliationName>



</affiliationsList>
<abstract language="eng">Hepatocellular carcinoma (HCC) is a common liver cancer-causing the high rate of mortality worldwide. The present study evaluates the possible protective role of lycopene during diethylnitrosamine (DEN)-induced HCC in rats for 16 weeks. A patch of 60 male rats was divided according to the required treatment into 6 groups. DEN was given to rats in drinking water (100 mg/L) to induce HCC. In the present study. The groups supplied with lycopene were administered with lycopene at 5, 10, and 20 mg/kg BW/orally/daily during the experiment. The DEN alone administered group induced alterations in all the investigated parameters. The lycopene pretreated DEN groups showed significant ameliorations in a dose-dependent manner against the deleterious alterations of DEN in the biological markers, oxidative stress, liver function, lipid profile, hematological parameters, serum inflammatory markers (TNF-¦Á and IL-6), immunohistochemical markers, caspase-3 liver content and histopathological changes, where the lycopene dose of 20 mg/kg showed better ameliorative effects. In conclusion, the oral administration of lycopene provides considerable protective effects against DEN-induced HCC which suggested the potential efficacy of lycopene as an additional chemopreventive agent in the treatment of HCC.</abstract>
<fullTextUrl format="pdf">http://pubs.sciepub.com/jfnr/10/4/2/jfnr-10-4-2.pdf</fullTextUrl>
<keywords language="eng"><keyword>lycopene</keyword>
<keyword>diethylnitrosamine</keyword>
<keyword>hepatocellular carcinoma</keyword>
<keyword>apoptosis</keyword>
<keyword>oxidative stress</keyword>
</keywords>
</record>
</records>
